Integration of mass drug administration programmes in Nigeria: The challenge of schistosomiasis.
about
Exploring health systems research and its influence on policy processes in low income countriesTriple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety studyHelminth infections: the great neglected tropical diseasesDevelopment of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE AdjuvantHow to (or not to) integrate vertical programmes for the control of major neglected tropical diseases in sub-Saharan AfricaEpidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in NigeriaA rationale for schistosomiasis control in elementary schools of the rainforest zone of pernambuco, Brazil.A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.High prevalence of helminths infection and associated risk factors among adults living in a rural setting, central Kenya: a cross-sectional study.Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Morbidity control of schistosomiasis by mass drug administration: how can we do it best and what will it take to move on to elimination?Human schistosomiasisIntegrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scaleAdult population as potential reservoir of NTD infections in rural villages of Kwale district, Coastal Kenya: implications for preventive chemotherapy interventions policyCommunity health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE ProjectA five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni.Assessing the WHO 50% prevalence threshold in school-aged children as indication for treatment of urogenital schistosomiasis in adults in central NigeriaSpatial heterogeneity of parasite co-infection: Determinants and geostatistical prediction at regional scalesBayesian risk maps for Schistosoma mansoni and hookworm mono-infections in a setting where both parasites co-exist.Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.Moderate and high endemicity of schistosomiasis is a predictor of the endemicity of soil-transmitted helminthiasis: a systematic review.Triple drug administration (TDA), with praziquantel, ivermectin and albendazole, for the prevention of three neglected tropical diseases in Nigeria.Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases.Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.Control of schistosomiasis in sub-Saharan Africa: progress made, new opportunities and remaining challenges.
P2860
Q21257221-161A99E5-B0EB-4163-81B7-52A9533F364EQ21562277-186DDB10-8642-42FC-9E8E-9A6C4E7B4955Q24648324-A7BA1798-0C1A-4F4F-BD50-CA75045605D1Q26991992-2216D7C5-5793-40E8-A256-332E9F380256Q28474748-627A50C8-101A-4ED7-926C-B269793D13FEQ28477441-B6577743-A8EE-414C-BDBE-CA62C8F4797FQ33418575-C270535A-F5D5-4342-B1B3-9BFEDF6C8443Q33717067-1161D19F-840E-4614-8D97-C7AB96B49D36Q33861714-A5E2A126-34B4-4A81-A3DE-E1FE7F1AB2C1Q33873632-AB86C0F2-3773-43D9-AC4F-8A379EB902D6Q34297640-91AA084A-D8D5-418C-9EB6-172B7C3008AAQ34375673-C693ECD1-DE05-4929-9773-A4A06E89082EQ34413522-0B56BCD2-E397-4182-BDCD-824F7270C58EQ34422256-6DF7B81D-8DE0-4109-A859-7A7338BAD462Q35540366-30BA6ECB-1796-424A-9953-A8A3E257CA63Q36450132-58246E46-53E7-4825-AA89-77D925D3321BQ36669066-71F87FA9-8223-487E-BEAE-8E7790A0CFA6Q36669077-FDDDE569-A9FD-438D-8984-13AE72F7A458Q37101345-139C8DD5-424D-494B-800B-900BAC97F95EQ37365768-9CDAEA6A-AF81-43F3-B5B6-72AB38F9AC9DQ37470553-5AAB715C-05F6-4C0B-88A4-F6E50454275CQ37826909-0FC8B0F9-E083-4EA2-8AAC-9ACE178FD15EQ38983362-C4081556-84A6-4599-BC2E-73A60CFEC44BQ39078371-FEAA29A3-CD67-4EE2-858A-AE9F35142F77Q43924383-091530DC-E1CF-422B-9D54-2F32569BD678Q45161426-BDD86C17-8731-4D96-A9DE-BE15DEB8F244Q46964347-D35D0E4F-8ACE-4214-948C-2D31D49DACF4
P2860
Integration of mass drug administration programmes in Nigeria: The challenge of schistosomiasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integration of mass drug admin ...... challenge of schistosomiasis.
@en
Integration of mass drug admin ...... challenge of schistosomiasis.
@nl
type
label
Integration of mass drug admin ...... challenge of schistosomiasis.
@en
Integration of mass drug admin ...... challenge of schistosomiasis.
@nl
prefLabel
Integration of mass drug admin ...... challenge of schistosomiasis.
@en
Integration of mass drug admin ...... challenge of schistosomiasis.
@nl
P2093
P356
P1476
Integration of mass drug admin ...... challenge of schistosomiasis.
@en
P2093
Abel Eigege
Donald R Hopkins
Emmanuel S Miri
Frank O Richards
M Y Jinadu
P304
P356
10.2471/BLT.06.029652
P407
P5008
P577
2006-08-01T00:00:00Z